Canada - English - Health Canada

pharmascience inc - methotrexate (methotrexate sodium) - solution - 15mg - methotrexate (methotrexate sodium) 15mg

Canada - English - Health Canada

pharmascience inc - methotrexate (methotrexate sodium) - solution - 17.5mg - methotrexate (methotrexate sodium) 17.5mg

Canada - English - Health Canada

pharmascience inc - methotrexate (methotrexate sodium) - solution - 20mg - methotrexate (methotrexate sodium) 20mg

Canada - English - Health Canada

pharmascience inc - methotrexate (methotrexate sodium) - solution - 22.5mg - methotrexate (methotrexate sodium) 22.5mg

Canada - English - Health Canada

pharmascience inc - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg

Canada - English - Health Canada

pharmascience inc - methotrexate (methotrexate sodium) - solution - 10mg - methotrexate (methotrexate sodium) 10mg

Canada - English - Health Canada

pharmascience inc - methotrexate (methotrexate sodium) - solution - 12.5mg - methotrexate (methotrexate sodium) 12.5mg

Canada - English - Health Canada

pharmascience inc - methotrexate (methotrexate disodium) - tablet - 2.5mg - methotrexate (methotrexate disodium) 2.5mg - antineoplastic agents

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 25 mg in 1 ml - methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. in acute lymphocytic leukemia, methotrexate is indicated for use in maintenance therapy in combination with other chemotherapeutic agents.   methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types. methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin’s lymphomas. methotrexate in high doses followed by leucovorin rescue in combination with other chemotherapeutic agents is effective in prolonging relapse-free survival in patients with non-metastatic osteosarcoma who have undergone surgical resection or amputation for the primary tumor. methotrexate is indicated in the symptomatic control of se

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 1 g - methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. in acute lymphocytic leukemia, methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents.  methotrexate is also indicated in the treatment of meningeal leukemia. methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types.  methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin’s lymphomas. methotrexate in high doses followed by leucovorin rescue in combination with other chemotherapeutic agents is effective in prolonging relapse-free survival in patients with non-metastatic osteosarcoma who have undergone surgical resectio